We Used to Have a Lyme Disease Vaccine. Are We Ready to Bring One Back?
At my animal hospital in upstate New York, an epicenter of the U.S. tick epidemic, my dog Fawn lets out a whimper as the veterinarian injects her with her annual Lyme disease shot. I roll my eyes. She doesn’t know how good she has it. The injection means that if a tick bites her (and in rural New York, a tick always does), the creepy crawly will feast on dog blood that’s been supercharged with a Lyme bacteria-killing substance, and Lyme disease won’t be transmitted to Fawn. I wish I could be shot up with that superpower. Currently, there is no human vaccine for Lyme disease—even though more than two...
Source: TIME: Health - June 17, 2021 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized Disease feature Source Type: news

Vaccination, previous infection, protect against gamma variant in animal model
(University of Wisconsin-Madison) In a new study using variant virus recovered from one of the original travelers, researchers in the US and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 17, 2021 Category: Infectious Diseases Source Type: news

Highly Multiplexed Cytokine Analysis in Small Animal Models
New cytokine analysis technology advances cancer therapeutics and vaccine development. (Source: The Scientist)
Source: The Scientist - June 16, 2021 Category: Science Tags: The Marketplace Source Type: news

New radiotracer visualizes protein key to cancer cell metabolism
A team from Stanford University has used a new molecular imaging agent to visualiz...Read more on AuntMinnie.comRelated Reading: Animal study suggests Ga-68 PET FAPI can detect lung fibrosis FDG-PET lymph node uptake after COVID-19 vaccines mimics cancer PET radiotracer tweaked for greater precision in AD detection 'Early frame' PET may reduce cost and burden in Alzheimer's disease PET imaging shows how COVID vaccines confound cancer detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2021 Category: Radiology Source Type: news

Animal study suggests Ga-68 PET FAPI can detect lung fibrosis
PET imaging with a gallium-68 (Ga-68)-labeled fibroblast activation protei...Read more on AuntMinnie.comRelated Reading: FDG-PET lymph node uptake after COVID-19 vaccines mimics cancer AI algorithm can predict severity, progression of COPD Thoracic radiologists give top tips for CT evaluation of lung parenchyma Preclinical lung imaging offers effective evaluation of drug candidates CT shows lung damage 6 months after COVID-19 recovery (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2021 Category: Radiology Source Type: news

New Phase 3 Study Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVICA® plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study demonstrated superior progression-free survival (PFS) of a once-daily, all-oral, fixed-duration regimen of I+V versus Clb+O as first-line treatment of CLL; the study also showed improved duratio...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

‘A Year Full of Emotions.’ What Kids Learned From the COVID-19 Pandemic
Too many young generations have been shaped by the global crises they faced—Depression-era poverty, Cold War nuclear fears. Add to them the COVID generation. The virus itself may typically go easier on kids than it does adults, but the mind of a child is another thing. It’s dependent on certainty, safety, the comfort of routine. Take all of that away—shutter schools, keep grandparents at a distance, cancel summer camps—and kids suffer. But as the following lightly-edited stories from young people show, they also grow and learn, gain maturity and wisdom. The virus has been tough; plenty of kids, it t...
Source: TIME: Health - June 12, 2021 Category: Consumer Health News Authors: Jeffrey Kluger and Allison Singer Tags: Uncategorized COVID-19 Source Type: news

To Improve Global Health Security, We Must Not Abandon Tackling Existing Epidemics
Over 600 million people in Africa require treatment for an NTD, making up 35% of the global burden. Credit: Uniting to Combat NTDsBy Thoko Elphick-PooleyHOVE, United Kingdom, Jun 11 2021 (IPS) As world leaders come together in the UK for the G7, the global response to COVID-19 and how we can build a better defence system against infection is at the forefront of discussions.  Whilst we applaud the incredible global efforts in tackling COVID-19 and support calls for vaccines to be shared equitably across the world, we also urge G7 leaders not to abandon efforts to tackle existing epidemics such as neglected tropical dis...
Source: IPS Inter Press Service - Health - June 11, 2021 Category: International Medicine & Public Health Authors: Thoko Elphick Pooley Tags: Headlines Health TerraViva United Nations Neglected Tropical Diseases (NTDs) Source Type: news

What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
You don’t want to be a virus in Dr. David Ho’s lab. Pretty much every day since the COVID-19 pandemic began, Ho and his team have done nothing but find ways to stress SARS-CoV-2, the virus that causes the disease. His goal: pressure the virus relentlessly enough that it mutates to survive, so drug developers can understand how the virus might respond to new treatments. As a virologist with decades of experience learning about another obstinate virus, HIV, Ho knows just how to apply that mutation-generating stress, whether by starving the virus, bathing it in antibodies that disrupt its ability to infect cells, ...
Source: TIME: Health - June 11, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature Genetics Magazine Source Type: news

We Need to Create an International Pandemic-Surveillance Network. Here ’s How
In the early 20th century, Scottish physician John Scott Haldane figured out why coal miners were suffocating on the job. Haldane undertook a series of experiments where he, himself, breathed several types of poison gas, and concluded that carbon monoxide was the culprit. He devised an early detection system whereby coal miners brought small animals—mice or canaries—down into the mines with them. These animals show symptoms of carbon monoxide poisoning before gas levels are too dangerous for workers, allowing them to evacuate in time. The system is, of course, no longer in broad use, but it has had a lasting im...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Julie Gerberding Tags: Uncategorized COVID-19 health Magazine Source Type: news

Poor People Are at Greater Risk During Pandemics. Climate Change Exacerbates the Problem
Preventing the next pandemic will require not only investment into infectious disease prevention and management, but a tectonic shift in our policies for global development more broadly. We are as strong as our weakest link, and the findings of the TIME survey must be understood through this perspective. Despite supporting the broad goal of zeroing out emissions, the experts polled said specific land use and climate change efforts such as modifying food habits and protecting ecosystems were relatively less important. In some ways, that makes sense, as they do seem distant in the desperate urgency of the moment. In this tim...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Sunita Narain Tags: Uncategorized COVID-19 health Magazine Source Type: news

The 10 Most Important Health Breakthroughs You Missed During the Pandemic
While most eyes were on COVID-19, researchers have also made groundbreaking advancements in other fields. Here’s a look. The other big vaccine news Public-health officials have long sought a vaccine against malaria, which infects up to 600 million people a year and kills 400,000, mostly children. This year, there was dramatic prog­ress toward that goal. In a study of 450 children in Burkina Faso, published in the Lancet in April, researchers reported that a new malaria vaccine, called R21, is 77% effective—just clearing the World Health Organization’s 75% efficacy standard. However, the sample gro...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 feature Innovation Magazine Source Type: news

Preventing the Next Health Crisis Depends on Health Workers. We Need 18 Million More
Over 115,000 health and care workers died during the COVID-19 pandemic. As a physician who’s cared for patients with COVID-19, malaria and Ebola, I’ve seen too many colleagues make the ultimate sacrifice on the frontlines. I’m not surprised experts responding to TIME’s survey ranked bolstering the world’s public health workforce, particularly in rural and remote regions, as one of the top five of nearly 50 strategies to prepare for the next pandemic. But I’m concerned they ranked this the least feasible strategy amongst the top five. Experts ranked high the need for new systems to raise ...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Raj Panjabi Tags: Uncategorized COVID-19 health Magazine Source Type: news

Torigen Pharmaceuticals Signs First Distribution Agreement with Victor...
Agreement will increase Torigen’s channel partnerships bringing the company’s autologous pet cancer vaccine to west coast veterinary clinics(PRWeb June 09, 2021)Read the full story at https://www.prweb.com/releases/torigen_pharmaceuticals_signs_first_distribution_agreement_with_victor_medical_company/prweb17992634.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 9, 2021 Category: Pharmaceuticals Source Type: news

Luring bacteria into a trap
(ETH Zurich) Researchers at ETH Zurich and the University of Basel have developed a vaccine that protects animals from Salmonella. These bacteria often escape the effects of vaccination by genetically modifying their protective coat. The researchers have succeeded in manipulating this process to lure the bacteria into an evolutionary trap. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 2, 2021 Category: Infectious Diseases Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Vaccine target for devastating livestock disease could change lives of millions
(Wellcome Trust Sanger Institute) The first ever vaccine target for trypanosomes, a family of parasites that cause devastating disease in animals and humans, has been discovered by scientists at the Wellcome Sanger Institute. By targeting a protein on the cell surface of the parasite Trypanosoma vivax, researchers were able to confer long-lasting protection against animal African trypanosomiasis (AAT) infection in mice. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 27, 2021 Category: Biology Source Type: news

RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of RYBREVANTTM (amivantamab-vmjw) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.[1] RYBREVANTTM is the first fully-human, bispecific antibody approved for the treatment of patients with NSCLC t...
Source: Johnson and Johnson - May 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

IMBRUVICA ® (ibrutinib)-Based Combination Regimen as a Fixed-Duration, First-Line Treatment for Chronic Lymphocytic Leukemia Demonstrates High Rates of Disease Control
May 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the fixed-duration cohort of the investigational Phase 2 CAPTIVATE study, showing that 95 percent of patients treated with combined IMBRUVICA® plus venetoclax were alive and progression-free at two years.[1] Deep remissions were seen across all subgroups, including patients with high-risk chronic lymphocytic leukemia (CLL).1 In addition, long-term data from the RESONATE-2 (PCYC-1115/1116) study will be presented, providing the longest follow-up Phase 3 data for any BTK inhibitor to date. Thes...
Source: Johnson and Johnson - May 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Bharat Biotech ’s plant in Karnataka to produce its first batch of Covaxin next month
The Hyderabad-based vaccine and bio-therapeutics firm has repurposed its veterinary vaccine plant at Malur industrial area near Bengaluru to produce Covaxin. The Union government had announced a support of Rs 65 crore for this plant to accelerate production of indigenous Covid-19 vaccines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 18, 2021 Category: Pharmaceuticals Source Type: news

Animals are our overlooked allies in the fight against Covid | Melanie Challenger
It ’s important to recognise the vital role they’ve played in development of vaccines and treatmentsA few weeks ago, I received my first shot of a vaccine against Covid-19. As the newly vaccinated exited the clinic, there was a mix of relief and elation on people ’s faces. We exchanged little smiles of solidarity. If we could have burst into spontaneous applause, I’m sure we would have done.Recently, the lead scientist for the Oxford/AstraZeneca vaccine, Prof Sarah Gilbert,was honoured with the RSA Albert Medal. There are rumours that Gilbert ’s team, along with the pioneers of the mRNA vaccin...
Source: Guardian Unlimited Science - May 17, 2021 Category: Science Authors: Melanie Challenger Tags: Medical research Vaccines and immunisation Coronavirus Animals Science World news Source Type: news

Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
Discussions are ongoing with the U.S. Food and Drug Administration regarding the approval of the vaccine regimen in the U.S. WHO Prequalification is often a prerequisite for national registrations of new vaccines and medicines in developing countries. Johnson & Johnson now looks forward to collaborating with the WHO’s African Vaccine Regulatory Forum (AVAREF) to progress national registrations of the Company’s Ebola vaccine regimen. The Company’s Ebola vaccine regimen is designed to be used proactively to induce immunity against Ebola virus disease in adults and children. Johnson & Johnson’s...
Source: Johnson and Johnson - May 13, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrates high immunogenicity against virus variants in preclinical study
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced together with its collaboration partner GSK, first preclinical data in a rat model, showing that its second-generation COVID-19 vaccine candidate, CV2CoV, induces high levels of antigen production as well as strong and dose-dependent immune responses in vaccinated animals. (Source: World Pharma News)
Source: World Pharma News - May 13, 2021 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

Jab-free dengue immunity could be just a click away
(University of Queensland) A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected every year. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 12, 2021 Category: Infectious Diseases Source Type: news

One Health Approach Key to Tackling Africa ’s Challenges
COVID-19 has shown that we need to act fast as changes at the interface of humans, livestock and wildlife are driving increased risk of emerging disease threats across the globe. Credit: Marc-André Boisvert/IPSBy Olanike AdeyemoIBADAN, Nigeria, May 11 2021 (IPS) The COVID-19 pandemic has shown us that global health challenges cannot be solved only by health sector interventions. Many of the recent epidemics — Ebola, Zika and even Covid-19 — are emerging infectious diseases transmissible from wildlife species. In addition, other global health challenges greatly impact people, livestock, wildlife and agri...
Source: IPS Inter Press Service - Health - May 11, 2021 Category: International Medicine & Public Health Authors: Olanike Adeyemo Tags: Africa Headlines Health TerraViva United Nations Source Type: news

Can experimental mRNA vaccines act as bio-weapons and transmit coronavirus spike proteins to the unvaccinated?
(Natural News) After Pfizer skipped animal trials for their new mRNA coronavirus vaccine, they began using various doses of foreign mRNA to experiment on human test subjects. This foreign vaccine mRNA stops the innate transcription process in human cells, providing new instructions for protein synthesis which basically overwrites the innate genetic expression from the body’s... (Source: NaturalNews.com)
Source: NaturalNews.com - May 6, 2021 Category: Consumer Health News Source Type: news

How we created the 'perfect storm' for pandemics
(University of East Anglia) The way we live has created the " perfect storm " for the evolution and transmission of infectious diseases like Covid-19.A new editorial shows how the world's vast population of people, pets and livestock has created an ideal breeding ground for infectious diseases which are passed between humans and animals.It shows how we urgently need to control the transmission of pathogens such as SARS-CoV-2 with vaccination passports, maximising genetic variation in livestock, and reducing meat consumption. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 6, 2021 Category: Infectious Diseases Source Type: news

VIVIENNE PARRY: You'll think I'm barking but we need to give Covid vaccines to animals too
VIVIENNE PARRY: You may think I have lost my marbles, particularly as many countries are still struggling to get regular vaccine programmes up and running for citizens, but hear me out… (Source: the Mail online | Health)
Source: the Mail online | Health - May 1, 2021 Category: Consumer Health News Source Type: news

Moderna Is Testing a New Version of Its COVID-19 Vaccine That Wouldn ’t Require Ultra-Cold Storage
As safety concerns over COVID-19 vaccines from AstraZeneca and Johnson&Johnson–Janssen have led to disruptions in the inoculation efforts of numerous countries relying on those shots, companies like Moderna are attempting to fill the resulting gaps. The Massachusetts-based biotech company announced on April 29 that it is investing billions to boost manufacturing facilities in Switzerland, Spain and the U.S., building enough capacity to produce up to 3 billion doses of its mRNA-based vaccine through 2022. The company’s vaccine technology differs from that of AstraZeneca and J&J, which both use an adenovi...
Source: TIME: Health - April 29, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Vaccine passports are a TRAP that sets the stage for Communism rollout across America
(Natural News) A popular trap for catching animals uses the foot hold design, where the animal steps in it and the trap grabs it by the foot and holds it indefinitely. It’s a live catch trap also known as a restraining trap because it captures the animal and restrains it for as long as needed.... (Source: NaturalNews.com)
Source: NaturalNews.com - April 24, 2021 Category: Consumer Health News Source Type: news

Janssen Provides Update on Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Plus Prednisone Combination
RARITAN, N.J., April 19, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that regulatory submissions based on the Phase 3 ACIS study, which evaluated the combination of ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC), will not be pursued. As presented at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cancers Symposium in February 2021, the ACIS study met its primary endpoint of radiographic progression-free survival (rPFS); ho...
Source: Johnson and Johnson - April 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New COVID-19 vaccine may offer broad protection from coronaviruses
A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing. Vaccines created by UVA Health's Steven L. Zeichner, MD, PhD, and Virginia Tech's Xiang-Jin Meng, MD, PhD, prevented pigs from being becoming ill with a pig model coronavirus, porcine epidemic diarrhea virus (PEDV). (Source: World Pharma News)
Source: World Pharma News - April 19, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Are vaccines variant-proof? Here ’s some good news
Moderna Inc. has also noted, though not published data, that its new mRNA-1273.351 vaccine was able to boost the immune response of previously vaccinated animals to provide increased activity against the B.1.351 variant. (Source: The Economic Times)
Source: The Economic Times - April 19, 2021 Category: Consumer Health News Source Type: news

Will You Need a Booster Shot of the COVID-19 Vaccine?
When the first COVID-19 vaccines from Pfizer-BioNTech and Moderna were authorized by the U.S. Food and Drug Administration in December 2020, most people breathed a sigh of relief since both shots were shown to be between 94% and 95% effective in protecting from COVID-19 symptoms. But public health experts warned that nobody really knew how long the protection would last, since the longest clinical trials in people only went to a few months. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and the chief medical advisor to President Joe Biden, suggested that additional booster ...
Source: TIME: Health - April 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Virginia Tech and UVA virologists develop broadly protective coronavirus vaccines
(Virginia Tech) A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 16, 2021 Category: Infectious Diseases Source Type: news

Scientists Report Creating the First Embryo With Human and Non-Human Primate Cells
In a ground-breaking experiment, researchers have successfully created the first human-monkey chimera. The work, published in the journal Cell, describes the the first embryo containing both human and monkey cells that was cultured for 20 days. Led by Juan Carlos Izpisua Belmonte, the study represents the culmination of decades of work in understanding early embryo development in non-human species, which Belmonte hopes will now apply to humans. But it is bound to raise serious ethical questions about the implications of combining human cells with those from a different species (even if it is a closely related one), and the...
Source: TIME: Health - April 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news

Mozambique: Mozambique Will Vaccinate Over Two Million Livestock
[AIM] Maputo -- A livestock vaccination drive underway across Mozambique will immunise more than two million animals against diseases such as anthrax, foot-and-mouth disease, brucellosis, lumpy skin disease, Newcastle fever and rabies, according to a report in Monday's issue of the Maputo daily "Noticias". (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 14, 2021 Category: African Health Source Type: news

Will Covid vaccines protect us against new variants? | Julian Tang
New strains such as the South African variant that ’s emerged in south London will require constant vigilance as lockdown easesAll viruses mutate. They do this to adapt and survive better in their specific host. The virus that causes Covid-19 is no different: it has moved from the animal realm, where it most likelyoriginated in bats, to the human world. Since then, scientists have been locked in a battle between the spread of the virus and the ability to immunise against it. We now have the vaccines to protect us against Covid-19 – but what happens when this virus mutates further, as it likely will?As lockdown ...
Source: Guardian Unlimited Science - April 14, 2021 Category: Science Authors: Julian Tang Tags: Coronavirus Infectious diseases Medical research Microbiology Science Vaccines and immunisation Society Pfizer AstraZeneca Pharmaceuticals industry World news UK news Source Type: news

Barilla Foundation Brings Health and Climate Together in New Double Pyramid
The Barilla Foundation New Double Pyramid includes seven cultural pyramids including ones for specific regions like South Asia where these rice workers come from. Other cultural regions include Latin America, East Asia, Nordic and Canada, USA, Mediterranean and Africa. Credit: Deepak Kumar / Unsplash By Alison KentishNEW YORK, Apr 12 2021 (IPS) Following an extensive scientific review, the Barilla Center for Food and Nutrition Foundation (BCFN) is preparing to launch a new food systems model which incorporates nutrition and climate. Researchers from the Foundation teamed up with counterparts from the Frederico II Univers...
Source: IPS Inter Press Service - Health - April 12, 2021 Category: International Medicine & Public Health Authors: Alison Kentish Tags: Climate Change Economy & Trade Environment Featured Food & Agriculture Food Security and Nutrition Food Sustainability Global Headlines Health Humanitarian Emergencies Natural Resources TerraViva United Nations Barilla Center for Source Type: news

What Are Toxin-Mediated Diseases?
Discussion A poison is a generic term for “a substance with an inherent property that tends to destroy life or impair health.” A toxin is more specific and is “any poison produced by an organism, characterized by antigenicity in certain animals and high molecular weight, and including the bacterial toxins that are the causative agents of tetanus, diphtheria, etc., and such plant and animal toxins as ricin and snake venom.” A toxin does not include those substances that are made synthetically produced. Venom is also a toxin that is used by animals and insects for predation or defense which can cause ...
Source: PediatricEducation.org - April 12, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Two New Studies Point to How AstraZeneca ’s COVID-19 Vaccine Is Linked to Blood Clots
In two papers published in the New England Journal of Medicine (NEJM), researchers in Europe provide the most detailed explanation yet for what is behind the clotting side effects reported among people getting vaccinated with the AstraZeneca COVID-19 shot. In both papers, researchers found that people getting the vaccine had higher levels of antibodies directed against a cluster of immune-related cells that the body might form in response to the vaccine. These clusters include platelets, which help blood to clot when you get cut or injured, and the antibodies stick to the platelet-complex and form dangerous clots that can ...
Source: TIME: Health - April 9, 2021 Category: Consumer Health News Tags: Uncategorized COVID-19 Source Type: news

South Africa: South Africa Must Harness the Power of Human and Veterinary Medicine Before the Next Deadly Virus Strikes
[Daily Maverick] A One Health approach to vaccine development has many strengths, including for health and food security on the continent. But this country needs to boost its capacity now. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 8, 2021 Category: African Health Source Type: news

< a href= " /news-events/nih-research-matters/nanoparticle-based-flu-vaccine " > Nanoparticle-based flu vaccine < /a >
A nanoparticle-based vaccine protected against a broad range of flu virus strains in animals. The vaccine may prevent flu more effectively than current vaccines. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - April 6, 2021 Category: Consumer Health News Source Type: news

What I ’ll Cherish About That Embarrassing Work-From-Home Wardrobe
A version of this article also appeared in the It’s Not Just You newsletter. Sign up here to receive a new edition every Sunday. Well hello! I’m so glad you’re here. As always, you can send comments to me at: Susanna@Time.com. I walked out of my apartment last Sunday afternoon like a Pandemic Eve, leaving her quarantine garden, still blissfully unselfconscious about how I looked, which was ridiculous. There were the mud boots I’ve been wearing daily since November because they’re so easy, the frayed yoga pants, and a workout shirt that is the color of a traffic cone. But what really tied it a...
Source: TIME: Health - April 4, 2021 Category: Consumer Health News Authors: Susanna Schrobsdorff Tags: Uncategorized Evergreen It's Not Just You Source Type: news

Before You Have That Bonfire of the Stretchy Pants, Consider Some Pandemic Wardrobe Habits You Should Keep
A version of this article also appeared in the It’s Not Just You newsletter. Sign up here to receive a new edition every Sunday. Well hello! I’m so glad you’re here. As always, you can send comments to me at: Susanna@Time.com. I walked out of my apartment last Sunday afternoon like a Pandemic Eve, leaving her quarantine garden, still blissfully unselfconscious about how I looked, which was ridiculous. There were the mud boots I’ve been wearing daily since November because they’re so easy, the frayed yoga pants, and a workout shirt that is the color of a traffic cone. But what really tied it a...
Source: TIME: Health - April 4, 2021 Category: Consumer Health News Authors: Susanna Schrobsdorff Tags: Uncategorized Evergreen It's Not Just You Source Type: news

‘World’s First’ Animal Covid-19 Vaccine Registered In Russia – Here’s What That Means
Millions of mink were culled due to widespread outbreaks of Covid-19, sparking fears for the future of the fur industry. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 31, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news

I Found a Rainbow At the End of My Hunt For a Vaccine Appointment
A version of this article also appeared in the It’s Not Just You newsletter. Sign up here to receive a new edition every Sunday. CHASING RAINBOWS (AND VACCINES) We, humans, are notoriously unreliable, superstitious narrators, always scanning the horizon for signs that validate what our hearts have already told us. Take me, for example. I keep telling people I was vaccinated at Hogwarts’ Manhattan campus under the waxing moon (it was a gibbous moon to be exact). How auspicious! Ok, so my COVID-vax site was really The City College of New York. But stepping through its big old gothic gates to receive a blessing of...
Source: TIME: Health - March 28, 2021 Category: Consumer Health News Authors: Susanna Schrobsdorff Tags: Uncategorized Evergreen It's Not Just You Source Type: news

I Found a Rainbow At the End of My Hunt For a Vaccine Appointment
A version of this article also appeared in the It’s Not Just You newsletter. Sign up here to receive a new edition every Sunday. CHASING RAINBOWS (AND VACCINES) We, humans, are notoriously unreliable, superstitious narrators, always scanning the horizon for signs that validate what our hearts have already told us. Take me, for example. I keep telling people I was vaccinated at Hogwarts’ Manhattan campus under the waxing moon (it was a gibbous moon to be exact). How auspicious! Ok, so my COVID-vax site was really The City College of New York. But stepping through its big old gothic gates to receive a blessing of...
Source: TIME: Science - March 28, 2021 Category: Science Authors: Susanna Schrobsdorff Tags: Uncategorized Evergreen It's Not Just You Source Type: news

Nanoparticle flu vaccine blocks seasonal and pandemic strains
(University of Washington School of Medicine/UW Medicine) Experimental flu shots have now been developed that protect animals from a wide variety of season and pandemic influenza strains. The vaccine candidate is being advanced toward clinical testing. If proven safe and effective, these next-generation influenza vaccines could replace seasonal options by protecting against more strains that current vaccines don't adequately cover. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 24, 2021 Category: Infectious Diseases Source Type: news

Covid vaccine used on apes at San Diego zoo trialled on mink
Experimental animal jabs could stop spillover back to humans, says firm behind vaccines for primatesAt the start of 2021, four orangutans and five bonobos becamethe first great apes at a US zoo to receive Covid-19 vaccinations. An outbreak in San Diego zoo ’s western lowland gorilla troop had caused panic among staff after the virus spread to the animals, probably from an asymptomatic zookeeper. Eight gorillas tested positive – with symptoms such as runny noses, lethargy and coughs – and there were fears the virus could spread to other primates.“We were approached by San Diego zoo asking if we had a...
Source: Guardian Unlimited Science - March 23, 2021 Category: Science Authors: Patrick Greenfield Tags: Animals Wildlife Vaccines and immunisation Infectious diseases Coronavirus Medical research World news Society Health Microbiology Science US news Environment Source Type: news